Loading page
What we know about this company
A dated company review is availableOracle Corporation
No eligible pre-cutoff material change after the previous company check.
TickerYou is watching this company, but we are not currently recommending it. An earlier full review was positive 6/10, but that view is historical.
$150.28
last session
Price only · no current Idea
Quarterly results window underway · through Sep 30 · Sep 1–30 · Confirmed range
This came from an earlier review. It is useful background, not a current Idea.
Oracle sells the databases and business software that run most of the Fortune 500. In the last two years it has also become one of the biggest sellers of the AI computing power — the racks of specialised chips — that companies like OpenAI use to train and run their models. It makes real money today: about $67 billion of sales last year and around $6 billion of operating profit in the last three months alone. The one thing that has to go right is that its huge order book actually turns into cash. About $638 billion of future orders are on the books, but more than half of that comes from a single customer, OpenAI. Oracle is spending enormous sums up front — over $50 billion last year on data centres and chips — and has borrowed heavily to do it, to the point where credit rating agencies have cut it to one notch above junk. The one thing that could go wrong is that OpenAI or the AI boom slows, Oracle cannot pay the debt from cash flow, and it has to sell a lot of new shares (already about $20 billion planned), shrinking your slice.
Loading company numbers
Loading latest quarterly results
Loading ownership and market expectations
Supplemental SEC filing context loads independently from the company evidence above.
Checking the newest complete filings from the large investors we follow. The rest of this page is ready while these delayed reports load.
TickerYou is checking this company, but no active investment Idea is open.
That review was positive with 6/10 research strength. It is history, not a current Idea.
Read the newest company check below. New facts can update the research, but watching a company does not turn it into a recommendation.
No eligible pre-cutoff material change after the previous company check.
No eligible pre-cutoff material change after the prior sweep. The 3m catalyst remains the mid-September Q1 result; the 1y view is high variance around OCI backlog conversion, AI datacenter funding and leverage.
Loading research history
Earlier company review · Record saved Aug 13, 2026 · check date unavailable. The original research wording and date checks stay available inside.
These events and risks came from an earlier company review. There is no current Idea.
An event can change what investors believe. A risk shows how our research could be wrong. The countdown is to the start of a window, not a promised event day.
Watch for the company to narrow this window, then judge the result against the assumptions below.
Company-confirmed by Oracle - Investor Relations - FAQ · Jun 10, 2026
No eligible pre-cutoff material change after the previous company check.
A company check updates what we know. It does not by itself turn this company into a current opportunity.
We rated 3 of 3 upcoming events. 0 are both likely and important.
2 older quarterly-results dates are hidden because a newer company check is shown above.
The date is not clear enough to calculate nearness.
The date is not clear enough to calculate nearness.
7 of 100 = chance 0.55 × effect 0.6 × date nearness 0.22.
Computed by TickerYou from 1254 completed daily closing sessions supplied by Yahoo Finance, through Sep 10, 2026. The Sep 11, 2026 quote-session candle was excluded because a delayed feed cannot prove it was final. No company fundamentals enter this reading.
Shorter and longer price trends point in different directions, so there is no clear trend.
Price movement can help with timing and can warn when the market disagrees with our Idea. It does not tell us what the business is worth.
Watch whether the close and the 50-session average ($140.52) move to the same side of the 200-session average ($167.89).
Last closing price
$152.94
Sep 10, 2026
Average price over 20 trading days
$149.68
Close is 2.2% above this average
Average price over 50 trading days
$140.52
Close is 8.8% above this average
Average price over 200 trading days
$167.89
Close is 8.9% below this average
Recent price speed
53.5 · balanced
A 14-day speed reading; lower than 30 is low and higher than 70 is high
Is the trend speeding up?
Above signal
Shows whether the shorter trend is pulling ahead of or behind the longer one
The moving averages are simple averages over exactly 20, 50, and 200 daily trading sessions. RSI uses Wilder's 14-session smoothing; a flat series is neutral at 50. MACD uses 12- and 26-session exponential averages with a 9-session signal. A window is never shortened when history is missing. Every comparison uses the final dated daily close—not an intraday quote—so all figures share one observation boundary. A candle dated to an active delayed-quote session is excluded because it may still be changing. These are trend and momentum references, not a Buy/Sell score.
We keep the original wording so readers can check the record. Any figures below belong to that older review and are not current guidance.
A high-growth AI infrastructure story with a genuine moat, but stapled to concentrated counterparty risk, stretched leverage, and shareholder dilution. The 55% drawdown has repriced some of that risk. Attractive as a sized position, not a full-conviction bet.
Each quarter is named by the fiscal quarter the company itself reported — the label its release used and its consensus estimate was quoted against — and by the month that quarter ended, taken from the filer's own XBRL period boundaries. A fiscal year need not follow the calendar, so Apple's Q2 runs January to March; naming the quarter end keeps that true in both calendars, and no quarter number is ever inferred from a date. Quarterly financials beside this card names the same quarter the same way. TickerYou takes the figures from the release and its filing; every word, sign and percentage is calculated by the app from those stored numbers. A post-release reaction appears only with the stored first-close measurement stamp; otherwise the card says the window is not established and computes no divergence. EPS here is on the basis consensus quotes — adjusted for most US names — so it can legitimately differ from the GAAP figure in Quarterly financials. Rows marked [backfilled] were confirmed from archived coverage after the fact — a lower evidence tier than live capture, and labelled so.
Q4 FY2026 · May 2026: EPS beat the stored consensus estimate, while revenue beat the stored consensus estimate. No post-release price reaction is asserted because its stamped measurement window is not established.
A surprise shows how the release differed from expectations, not whether the business is good or the thesis is right. The price reaction shows repricing, not its cause.
Watch whether the next comparable release confirms the result; one beat or market move does not establish a durable trend.
Quarter ended May 31, 2026 · Reported Jun 10, 2026 · stock move after results · not shown
[backfilled] Oracle delivered 21% revenue growth with cloud revenue up 47% and OCI (IaaS) surging 93%; remaining performance obligations hit $638 billion, up $85 billion sequentially in a single quarter, and the company raised FY2027 non-GAAP EPS guidance to $8.05.
Quarter ended Feb 28, 2026 · Reported Mar 10, 2026 · stock move after results · not shown
[backfilled] Oracle delivered its first quarter in over 15 years with both total revenue and non-GAAP EPS growing 20%+ organically in USD, led by 84% IaaS growth to ~$4.9B and RPO surging to $553B; management raised FY2027 revenue guidance to $90B.
Quarter ended Nov 30, 2025 · Reported Dec 10, 2025 · stock move after results · not shown
[backfilled] Revenue of $16.1B grew 14% Y/Y; non-GAAP EPS of $2.26 included a $2.7B one-time gain from Oracle's Ampere stake sale that inflated the headline figure — core underlying EPS was ~$1.33; shares fell 12% as investors absorbed the revenue result and a $50B AI capex plan disclosed on the call.
Quarter ended Aug 31, 2025 · Reported Sep 9, 2025 · stock move after results · not shown
[backfilled] Non-GAAP EPS of $1.39 on $13.74B revenue (+7% YoY); cloud services grew 10% and OCI bookings surged on AI infrastructure demand; management raised FY2026 revenue guidance above $66B and guided Q2 non-GAAP EPS to $1.47–$1.51.
Computed from SEC filings — never model output. Each quarter is named by the fiscal quarter the company itself reported and the month that quarter ended, through the same resolver the Earnings card beside this one uses; where no release established a fiscal label, the quarter is named by its end alone rather than by a quarter number guessed from the date. EPS is GAAP diluted, as filed, so it can legitimately differ from the adjusted figure in the Earnings card (consensus is quoted adjusted). Y/Y compares the same fiscal quarter a year earlier; a comparison that cannot be made honestly is an em-dash that says why.
Q4 FY2026 · May 2026: Revenue grew 20.6% year over year; net income grew 25.6% year over year; and net profit margin was 22.4%, up 0.9 percentage points.
Comparing the same fiscal quarter a year earlier controls for seasonality. Revenue direction and margin direction together show whether sales are translating into profit, but one quarter is evidence—not a complete thesis.
Watch whether the next comparable quarter confirms both the sales direction and the margin direction.
Complete SEC 13F filings only. These delayed reports show filed share amounts, not a manager’s full portfolio, intent, or a proven trade.
4 of 14 recent complete filings report ordinary shares. Compared with the prior report: 1 new positions, 2 with more shares, and 1 with fewer shares.
A large, repeated position can support a research story, but these filings arrive late and do not show an investor’s full portfolio or reason for owning the stock.
Look for the same investor to keep a meaningful position across several reports.
No numeric score or recommendation is made from these delayed filings. They are one piece of background evidence, not a buy or sell signal.
14 current complete filings of 16 tracked managers. 2 investors have only an older filing and are left out of this current view. Current holding dates span Mar 31, 2026 to Jun 30, 2026.
| (USD) | Q4 FY2026Quarter ended May 2026 | vs last year |
|---|---|---|
| Revenue | $19.18 B † | |
| Profit after costs | $4.30 B † | |
| Profit per share | 1.45 † | |
| Profit margin | 22.4% |
† derived: the fiscal year minus its three reported quarters — no 10-K reports a Q4 figure directly. For EPS this assumes per-share figures add across the year.
| Quarter | Revenue | Y/Y | Net income | Margin |
|---|---|---|---|---|
| Q3 FY2026 · Feb 2026 | $17.19 B | $3.72 B | 21.6% | |
| Q2 FY2026 · Nov 2025 | $16.06 B | $6.13 B | 38.2% | |
| Q1 FY2026 · Aug 2025 | $14.93 B | $2.93 B | 19.6% | |
| May 2025 | $15.90 B † | $3.43 B † | 21.5% | |
| Feb 2025 | $14.13 B | $2.94 B | 20.8% | |
| Nov 2024 | $14.06 B | $3.15 B | 22.4% | |
| Aug 2024 | $13.31 B | $2.93 B | 22.0% | |
| May 2024 | $14.29 B † | $3.14 B † | 22.0% |
ORCL is 0.86% of Bridgewater Associates's disclosed portfolio ($210.00 M). Holdings as of Jun 30, 2026. Reported in all 6 quarters we can see.
ORCL is 0.41% of Soros Fund Management's disclosed portfolio ($33.14 M). Holdings as of Jun 30, 2026. Reported in 2 consecutive quarters.
ORCL is 0.08% of Citadel Advisors's disclosed portfolio ($697.00 M). Holdings as of Jun 30, 2026. Reported in all 2 quarters we can see.
Market-neutral / multi-strategy: Citadel often reports shares, calls, and puts at the same time. These rows show reported exposure, not a simple bullish or bearish bet.
ORCL is 0.00% of Renaissance Technologies's disclosed portfolio ($245.45 K). Holdings as of Jun 30, 2026. Reported in 1 consecutive quarter.
Citadel Advisors (Ken Griffin) reports a PUT option ($1.47 B). The filing does not prove whether it is a bet or a hedge, so options never count as ordinary shares above.
Citadel Advisors (Ken Griffin) reports a CALL option ($1.56 B). The filing does not prove whether it is a bet or a hedge, so options never count as ordinary shares above.
3 newly or higher reported, 1 lower reported. Reported amounts only; corporate actions are not normalized.
Reported by 4 of 14 managers with a current filing; at least 0.5% of disclosed 13F value for 1.
Largest reported position: Bridgewater Associates (Ray Dalio) at 0.86% of disclosed 13F value ($210.00 M).
Across 6 quarters of stored filings: 7 newly or higher comparisons, 6 lower or absent, 0 unchanged, across 5 managers. Corporate actions are not normalized.
No numeric score is shown: filing comparisons are not adjusted for splits or other corporate actions, so reported changes cannot be treated as trades.
13Fs can arrive up to 45 days after quarter end. They omit short positions, cash, and securities outside the SEC's 13(f) list. Higher, lower, new, and absent describe filed share amounts, not proven purchases or sales; splits and other corporate actions are not normalized. This is context for a thesis, never a call by itself.
Append-only company checks, newest evidence first. Evidence dates come from frozen research cutoffs; older rows without a cutoff are labelled by publication time instead. Multiple checks are preserved, never silently merged into one conclusion.
No eligible pre-cutoff material change after the prior sweep. The 3m catalyst remains the mid-September Q1 result; the 1y view is high variance around OCI backlog conversion, AI datacenter funding and leverage.
2026-09 (company-confirmed) mid-September fiscal Q1 2027 earnings reporting date window was stated by Oracle investor relations.
Checked Oracle EDGAR entity page for recent 8-K, 10-Q, 10-K, ownership and beneficial-ownership filings.
Checked Oracle June 10 Q4 release as the current eligible operating baseline for OCI, RPO, funding and Q1 guidance.
Slightly more cautious than the 2026-08-28 sweep because OpenAI infrastructure leadership turnover adds counterparty execution noise. The 3m catalyst is the confirmed September Q1 window; the 1y case remains high variance around OCI backlog conversion, AI datacenter capex, leverage, and customer concentration.
2026-09 (company-confirmed) mid-September fiscal Q1 2027 earnings release window was stated by Oracle investor relations.
No material change since the newest prior sweep. The confirmed September earnings window remains the 3m catalyst; the 1y view is still high variance around OCI backlog conversion, AI datacenter capex, leverage, and customer concentration.
2026-09 (company-confirmed) mid-September fiscal Q1 2027 earnings release window was stated by Oracle investor relations.
Evidence checked Aug 26, 2026 · 2 recorded assessments
No material change since the newest prior sweep at 2026-08-26T17:39:11.92+00:00. The confirmed September earnings window is the 3m catalyst; the 1y case remains high variance around OCI backlog conversion, AI datacenter capex, leverage, and customer concentration.
2026-09 (company-confirmed) earnings release window for Oracle fiscal Q1 2027 was stated by Oracle investor relations as mid-September.
Evidence checked Aug 24, 2026 · 2 recorded assessments
No material change since the newest prior sweep. ORCL remains the highest-variance name here: attractive if OCI backlog converts, but 3m and 1y risk are still capex intensity, leverage, and concentrated AI-infrastructure counterparties.
Checked Oracle investor FAQ for next earnings release window
Published Aug 19, 2026 · 2 recorded assessments
Highest-variance name in the sweep: a historic OCI backlog (~$300B OpenAI, large total RPO) against ~$50B capex, rising debt, and a stock well off its 2025 highs on AI-bubble and execution fears. The bull case is backlog conversion from 2027; the bear case is capex outrunning cash generation. Could not confirm a specific SEC filing dated within the last month — filings left empty rather than guessed. Watch the Sept ~9 print for OCI RPO and capex guidance.
Checked Oracle EDGAR entity landing page for recent 8-K, 10-Q, 10-K, ownership and beneficial-ownership filings.
Checked Oracle fiscal 2026 10-K directly on EDGAR as the latest annual filing baseline after no priority last-month filing was found.
Checked Oracle June Q4 release for current OCI, RPO, financing, and Q1 FY2027 guidance baseline.
Checked WSJ report on OpenAI data-center leadership departure for Oracle Stargate and counterparty execution risk.
Fundamental for Oracle only as risk context: the article ties the departed OpenAI data-center executive to Stargate with Oracle and SoftBank, so it bears on the execution risk around Oracle's AI infrastructure counterparty exposure even though it is not an Oracle filing or guidance change.
source ↗Checked Oracle EDGAR entity landing page for recent filings and last-days filing status.
Checked Oracle EDGAR annual filing baseline after recent-filing search found no priority last-month filing to add.
Checked recent Axios AI infrastructure spending article for Oracle-related capital-structure implications.
The article includes Oracle among hyperscalers analyzed for off-balance-sheet AI infrastructure commitments and reinforces capital-intensity risk, but it is third-party analysis rather than a new Oracle-specific filing, contract, or guidance update.
source ↗Checked Oracle EDGAR annual filing baseline after recent-filing search found no priority last-days filing to add.
Checked recent Oracle-related datacenter financing commentary for possible balance-sheet risk implications.
Not fundamental for Oracle by itself because it is outside commentary on sector financing structures rather than a new Oracle filing, contract, guidance change, or balance-sheet event. It does keep investor attention on AI infrastructure financing risk.
source ↗No material change since the 2026-08-24 prior sweep. The September Q1 earnings window remains the 3m catalyst; the 1y view is still high variance, driven by OCI backlog conversion versus capex, leverage, and customer-concentration risk.
2026-09 (company-confirmed window) earnings release timing for fiscal Q1 2027 was stated by Oracle investor relations as mid-September.
Checked Oracle EDGAR entity landing page for recent filings and last-days filing status.
Checked Oracle EDGAR company page for recent filings and last-days filing status
No new opened fundamental item changes the prior view: ORCL remains a leveraged AI-infrastructure backlog story, attractive only if cloud growth converts faster than capex and debt pressure build.
Checked ORCL next earnings date and recent earnings-calendar data
Checked Oracle EDGAR company page for recent SEC filings
Deepens the Oracle–OpenAI commercial tie and gives OCI customers a native path to frontier models, supporting cloud consumption and the AI-infrastructure revenue narrative.
The RPO/backlog is enormous but so is capital intensity; capex jumped from ~$21B to ~$50B and financing was raised, making free-cash-flow timing and contract conversion (starting 2027) the central risk/reward.
source ↗Oracle is executing at scale — $638B backlog, 93% IaaS growth, Google Cloud partnership, 21% Q4 revenue growth — but at steep financial risk: $122B long-term debt, $55.7B FY2026 capex, and −$23.7B free cash flow. Layoffs signal margin defense is already underway. Sep 14 earnings is the clearest near-term test of whether backlog converts at a pace that justifies the leverage.
Double-digit percentage cuts on some teams as Oracle manages payroll against negative free cash flow (−$23.7B in FY2026); this is structural margin defense ahead of Sep 14 earnings and directly relevant to operating margin trajectory for Q1 FY2027.
source ↗Google Cloud partnership confirms OCI as a preferred AI compute platform outside the Big Three hyperscalers; $638B performance obligation backlog (93% cloud infra growth) is the core bull case — the Sep 14 earnings will test conversion velocity against the debt-service clock.
source ↗The capex-vs-FCF gap is the central risk: Oracle is leveraging at scale betting the $638B backlog converts before debt service constrains flexibility. If cloud infra demand decelerates, the leverage amplifies the downside disproportionately.
source ↗Three checks use SEC filings alone. The net-buyback check requires matching stated filing and quote currencies, a compatible single-ticker SEC share-unit receipt, and a dated provider quote; its row explains any refusal. One dated deep-review judgement is marked researched; missing checks are excluded, never treated as zero.
The score combines 3 established checks. Higher means the recorded share structure has been more protective of each holder’s ownership slice.
A company can grow while each shareholder owns a smaller slice. Share issuance and stock pay can offset part of the business gain. Strongest known check: pay in stock, vs revenue (3.7144765948602227/10).
Lowest known check: what the share count did (2.297320208859864/10). Still unestablished: buybacks net of new stock sold; room left under the charter.
30/100
protection from new shares · 3 of 5 checks ready
+6.4% between the 2025-09-05 and 2026-09-07 filing cover pages.
Employees were paid $4.81B in stock against $67.36B of revenue — 7.1% — in the year through 2026-05-31.
the SEC maps this filer to multiple quoted tickers (ORCL, ORCL-PD), so one class price cannot be multiplied by the entity-wide count
The deep review’s dated judgement (published Aug 13, 2026; evidence cutoff unavailable): how much of a 1% ownership slice at that review could survive through its horizon.
the SEC maps this filer to multiple quoted tickers (ORCL, ORCL-PD), so one class price cannot be multiplied by the entity-wide count
review saved Aug 13, 2026 · check date unavailable
Larry Ellison owns 40.6% of Oracle (about 1.17 billion shares, worth roughly $165B), per the 2026 proxy statement. He effectively controls the company. About 346 million of his shares — around $40B worth — are pledged as collateral for personal loans; Oracle says these are term loans, not margin calls, but a severe drop would still be a tail risk. For years Oracle shrank its share count with buybacks, and that quietly lifted Ellison's slice from 23% to 41% without him buying more. That era is ending. In early 2026 stock pay to employees exceeded buybacks for the first time in years, and management has said it will sell about $20B of new stock in FY2027 to help fund the AI buildout. Translation: your slice of Oracle will get smaller over the next year or two, not bigger. That is a real headwind on top of any operating result.
A conditional model using SEC filings and a delayed-market quote from Yahoo Finance for the Sep 11, 2026 session. It is not a market forecast or analyst consensus.
The required growth rate cannot be established from compatible current inputs.
A high number means the company must grow quickly to justify today's price. A low number gives the business more room to disappoint.
Watch sales growth and operating profit. If either changes, this required-growth number can change too.
— what the price assumes could not be computed: total debt is not established — missing debt is never treated as zero.
The last deep review estimated 15–28% yearly growth. That is useful history, but there is no current Idea, so we do not compare it with today's price. review saved Aug 13, 2026 · check date unavailable.
1M
3M
6M
1Y
Computed from SEC filings — never model output. Blank means it cannot be computed honestly.
Revenue grew 17.3% versus the comparable filing period, while operating margin was 30.6%.
Revenue shows whether demand is expanding, while operating and free-cash-flow margins show how much of those sales becomes profit and cash. Net cash or debt affects how resilient that result is.
Watch whether the next comparable filing confirms the revenue direction and whether operating and cash-flow margins hold or improve.
Every figure comes from an SEC filing and carries the day it was measured. Nothing here is estimated.
The filed share count increased 6.41% over roughly a year. That is dilution: each existing share represents a smaller percentage ownership slice.
A growing business can still deliver weak per-share progress when the share count grows too. The count says what happened to ownership slices, not why the company issued shares.
Watch the next filing cover page and the cash-flow and stock-compensation disclosures to see whether issuance continues and what caused it.
3.02 B
total shares when last reported · Sep 7, 2026 · 5 days ago
The SEC’s structured data establishes the total share count but carries no count of the shares structurally excluded from ordinary trading. Control and affiliate holdings, restricted stock and locked-up shares are disclosed publicly — in proxy statements, prospectuses and 8-Ks — as prose with no tag to read them from, and have not been researched into a figure this card can pair with the total above.
Share count increased 6.41% — dilution risk: each existing share owns a smaller percentage of the company.
Both counts in full, exactly as each cover page printed them, and both bars measured from zero against the larger — so a small move looks small.
measured May 31, 2026, 3 months ago — from the 10-K filed Jun 22, 2026
Market value of shares held by non-affiliates under the SEC filing definition. This is a dollar amount, not a share count. It is never converted into one to fill the line above.
Not researched yet. Release dates, tranche sizes, the shares issued at IPO and the insider breakdown are prose in the prospectus and in 8-Ks, with no XBRL tag to read them from. They appear here once TickerYou research can quote the source clause behind each figure—never estimated in the meantime.